Cyclic Pyranopterin Monophosphate class drugs

1 result

Nulibry (fosdenopterin hydrobromide)

(fosdenopterin hydrobromide)
Sentynl Therapeutics, Inc.
Usage: NULIBRY is indicated for reducing the risk of mortality in patients with molybdenum cofactor deficiency (MoCD) Type A.